Gina Maki

14 papers receiving 297 citations

Hit Papers

Antibiotics and antimicrobial resistance in the COVID-19 ...2021202620222024202150100150

Peers

Gina Maki
Comparison fields: 5 of 81
  • Applied Microbiology and Biotechnology 153
  • Infectious Diseases 81
  • Molecular Medicine 64
  • Epidemiology 51
  • General Health Professions 45
Replace Germán Peñalva with:
Germán Peñalva Spain
Francesco M. Labricciosa Italy
Stuart Bond United Kingdom
Appiah-Korang Labi Ghana
Daniel Echeverría-Esnal Spain
Ana Belén Guisado-Gil Spain
Wanda Cornistein Argentina
Mushira Enani Saudi Arabia
Manal Algethamy Saudi Arabia
L. Gayani Tillekeratne United States
Gina Maki relative to Germán Peñalva Spain Germán Peñalva's profile →
Citations per field
00.5×1.5×
Germán Peñalva · 1×
Citations per year

Countries citing papers authored by Gina Maki

Since Specialization
Citations

This map shows the geographic impact of Gina Maki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gina Maki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gina Maki more than expected).

Fields of papers citing papers by Gina Maki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gina Maki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gina Maki. The network helps show where Gina Maki may publish in the future.

Co-authorship network of co-authors of Gina Maki

This figure shows the co-authorship network connecting the top 25 collaborators of Gina Maki. A scholar is included among the top collaborators of Gina Maki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gina Maki. Gina Maki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 0
2 5
3 0
4 1
5 18
6 56
7
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settingsbreakdown →
176
8 4
9 2
10 20
11 1
12 1
13 1
14 5
15 0
16 1
17 11

About Gina Maki

Gina Maki is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 17 papers that have together received 302 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (8 papers), Antibiotic Resistance in Bacteria (4 papers) and Nosocomial Infections in ICU (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (153 citations), Molecular Medicine (64 citations) and Critical Care and Intensive Care Medicine (37 citations). Gina Maki has collaborated with scholars based in United States, Nepal and Argentina. Frequent co-authors include Marcus Zervos, Gérard Joseph, Jacques Boncy, Hatim Sati, Michael F. Canarie, Pilar Ramón-Pardo, Paul E. Kilgore, Natael Fénélon, Patrick Dély and Ana del Rı́o. Their work appears in journals such as SHILAP Revista de lepidopterología, American Journal of Tropical Medicine and Hygiene and Infection Control and Hospital Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026